(Q54566916)

1 June 2018

title

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma. (English)

1 reference

1 June 2018

0 references

1 reference

Masumi Eto

2

0 references

author name string

Mizue Terai

1

1 reference

1 June 2018

Garbo D Young

3

1 reference

1 June 2018

David Berd

4

1 reference

1 June 2018

Michael J Mastrangelo

5

1 reference

1 June 2018

Yutaka Tamura

6

1 reference

1 June 2018

Kenichi Harigaya

7

1 reference

1 June 2018

Takami Sato

8

1 reference

1 June 2018

publication date

19 August 2011

1 reference

1 June 2018

Cancer Immunology, Immunotherapy

published in

1 reference

1 June 2018

volume

61

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

145-155

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s00262-011-1084-5

exact match

0 references

cites work

Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Immunomodulatory changes in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Gp130 and the interleukin-6 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

The Brn-2 transcription factor links activated BRAF to melanoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1084-5

10.1007/S00262-011-1084-5

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

release_xxpjzvdr4jaytjsgru7ywouxai

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xxpjzvdr4jaytjsgru7ywouxai

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

1 June 2018